Literature DB >> 29755597

5-Fluorouracil may enrich cancer stem cells in canine mammary tumor cells in vitro.

Bin Zhou1, Yipeng Jin2, Di Zhang2, Degui Lin2.   

Abstract

Mammary gland carcinomas are the most common neoplasms in women and unsterilized female dogs. Owing to the existence of cancer stem cells (CSCs), chemotherapy is not able to cure these types of diseases completely. A number of studies have demonstrated that CSCs are resistant to chemotherapeutic drugs, but whether canine mammary tumor cells that have acquired resistance to 5-fluorouracil (5-FU) exhibited properties of CSCs remains unknown. The aim of the present study was to investigate whether 5-fluorouracil-resistant canine mammary tumor cells exhibited properties of CSCs. CSCs were analyzed using western blot assays, ultra-low attachment sphere cultures, flow cytometry and migration (wound healing and Transwell) assays. The results indicated that, compared with parental cells, proteins associated with the Wnt/β-catenin signaling pathway and aldehyde dehydrogenase 1 were overexpressed, the number and size of spheres in the 5-FU-resistant cells were increased, the ratio of CD44+/CD24-/low cells was increased and the migratory ability was improved in vitro compared with the 5-FU-susceptible cells. In conclusion, stimulation with chemotherapeutic drugs including 5-FU is a good method for increasing the proportion of canine mammary tumor stem cells in vitro, which may provide further understanding of chemotherapeutic methods and CSCs.

Entities:  

Keywords:  5-fluorouracil; cancer stem cells; canine mammary tumor cell; drug resistance; migration

Year:  2018        PMID: 29755597      PMCID: PMC5943676          DOI: 10.3892/ol.2018.8267

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  29 in total

Review 1.  EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer.

Authors:  A Singh; J Settleman
Journal:  Oncogene       Date:  2010-06-07       Impact factor: 9.867

2.  Cancer stem cells and EMT in carcinoma.

Authors:  Adrian Biddle; Ian C Mackenzie
Journal:  Cancer Metastasis Rev       Date:  2012-02-03       Impact factor: 9.264

Review 3.  The relevance of EMT in breast cancer metastasis: Correlation or causality?

Authors:  Ruben Bill; Gerhard Christofori
Journal:  FEBS Lett       Date:  2015-05-12       Impact factor: 4.124

4.  Uptake and retention of daunomycin by mouse leukemic cells as factors in drug response.

Authors:  D Kessel; V Botterill; I Wodinsky
Journal:  Cancer Res       Date:  1968-05       Impact factor: 12.701

5.  Inhibition of transient receptor potential channel 5 reverses 5-Fluorouracil resistance in human colorectal cancer cells.

Authors:  Teng Wang; Zhen Chen; Yifei Zhu; Qiongxi Pan; Yanjun Liu; Xiaowei Qi; Linfang Jin; Jian Jin; Xin Ma; Dong Hua
Journal:  J Biol Chem       Date:  2014-11-17       Impact factor: 5.157

Review 6.  Tumour stem cells and drug resistance.

Authors:  Michael Dean; Tito Fojo; Susan Bates
Journal:  Nat Rev Cancer       Date:  2005-04       Impact factor: 60.716

7.  Population-based incidence of mammary tumours in some dog breeds.

Authors:  L Moe
Journal:  J Reprod Fertil Suppl       Date:  2001

Review 8.  Metastasis suppressors in breast cancers: mechanistic insights and clinical potential.

Authors:  Christopher R Bohl; Sitaram Harihar; Warren L Denning; Rahul Sharma; Danny R Welch
Journal:  J Mol Med (Berl)       Date:  2013-12-06       Impact factor: 4.599

9.  The role of CD44+/CD24-/low biomarker for screening, diagnosis and monitoring of breast cancer.

Authors:  Rosa Camerlingo; Giuseppe Andrea Ferraro; Francesco De Francesco; Maurizio Romano; Gianfranco Nicoletti; Maurizio Di Bonito; Massimo Rinaldo; Francesco D'Andrea; Giuseppe Pirozzi
Journal:  Oncol Rep       Date:  2013-12-23       Impact factor: 3.906

Review 10.  ALDH1 as a functional marker of cancer stem and progenitor cells.

Authors:  Julie Douville; Raymond Beaulieu; Danuta Balicki
Journal:  Stem Cells Dev       Date:  2009 Jan-Feb       Impact factor: 3.272

View more
  6 in total

Review 1.  CSCs in Breast Cancer-One Size Does Not Fit All: Therapeutic Advances in Targeting Heterogeneous Epithelial and Mesenchymal CSCs.

Authors:  Andrew Sulaiman; Sarah McGarry; Xianghui Han; Sheng Liu; Lisheng Wang
Journal:  Cancers (Basel)       Date:  2019-08-07       Impact factor: 6.639

2.  Celastrol Inhibits Canine Mammary Tumor Cells by Inducing Apoptosis via the Caspase Pathway.

Authors:  Guoxing Ou; Xianyu Jiang; Ang Gao; Xiaolong Li; Zijun Lin; Shimin Pei
Journal:  Front Vet Sci       Date:  2022-02-04

3.  Effects of Para-Toluenesulfonamide on Canine Melanoma Xenotransplants in a BALB/c Nude Mouse Model.

Authors:  Chien-Teng Lin; Chuen-Fu Lin; Jui-Te Wu; Hsiao-Pei Tsai; Shu-Ying Cheng; Huei-Jyuan Liao; Tzu-Chun Lin; Chao-Hsuan Wu; Yu-Chin Lin; Jiann-Hsiung Wang; Geng-Ruei Chang
Journal:  Animals (Basel)       Date:  2022-09-02       Impact factor: 3.231

4.  In vitro chemosensitivity of a canine tumor venereal transmissible cancer cell line.

Authors:  Moisés Armides Franco Molina; Edson Antonio Santamaría-Martínez; Silvia Elena Santana Krimskaya; Diana Ginette Zarate-Triviño; Jorge R Kawas; Yareellys Ramos Zayas; Natanael Palacios Estrada; Heriberto Prado García; Paola Leonor García Coronado; Cristina Rodríguez Padilla
Journal:  Front Vet Sci       Date:  2022-08-18

5.  A Marine Collagen-Based Biomimetic Hydrogel Recapitulates Cancer Stem Cell Niche and Enhances Progression and Chemoresistance in Human Ovarian Cancer.

Authors:  SooHyeon Moon; YeJin Ok; SeonYeong Hwang; Ye Seon Lim; Hye-Yoon Kim; Yong-Jin Na; Sik Yoon
Journal:  Mar Drugs       Date:  2020-09-29       Impact factor: 5.118

6.  Functional analysis of CD44 variants and xCT in canine tumours.

Authors:  Atsushi Tanabe; Kento Kimura; Hana Tazawa; Takuya Maruo; Masayuki Taguchi; Hiroeki Sahara
Journal:  Vet Med Sci       Date:  2020-11-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.